Xbrane Biopharma certified as a Great Place to Work®
Other Corporate Information
Based on the results of a company-wide employee survey Xbrane Biopharma has been officially awarded the Great Place to Work® certificate by the Great Place to Work® Institute
Solna, Sweden July 2, 2021. Xbrane Biopharma (“Xbrane”), a biosimilar developer with the aim to make biological drugs affordable for wider patient populations globally, today announces its certification to a Great Place to Work® 2021 by the independent institute Great Place to Work®, a global authority on workplace culture and leadership behaviours. The certification is primarily based on ratings provided by Xbrane employees in an anonymous survey called Trust Index™ that assesses perspectives on leadership, pride and teamwork.
“We are very pleased that Xbrane has been certified as a Great Place to Work®. We strive to become a purpose-driven organization with strong values, which I think is reflected in our high Trust Index™. This is an important foundation for the future success of the company, and to fulfil our goal – to become the most attractive employer within our field”, says Martin Åmark, CEO.
95 percent of Xbrane’s employees participated in the Great Place to Work® survey. The cornerstones of the company's culture are; “Make it happen”, “Beat yesterday”, “Impossible is nothing” and “We win as one”.
About Great Place to Work®
Great Place to Work® is the global authority on workplace culture. Since 1992, they have surveyed more than 100 million employees around the world and used those deep insights to define what makes a great workplace. Their unparalleled benchmark data is used to recognize Great Place to Work-Certified™ companies and the Best Workplaces™ in more than 60 countries, including the 100 Best Companies to Work For® and World's Best list published annually in Fortune. Everything they do is driven by the mission to build a better world by helping every organization become a Great Place to Work for All™. To learn more, visit www.greatplacetowork.com.